Tevogen Bio Announces Series A-1 Preferred Stock InvestmentGlobe Newswire • about 2 months agoWARREN, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings ('Tevogen Bio') (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically...